Recent Updates
Recently added Catalysts
GNLX Positive Sentiment Score: 70/100

Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference

Wednesday, November 6, 2024 1 min read
Key Takeaway: Genelux Corporation announced its participation in the Guggenheim Inaugural Healthcare Innovation Conference, scheduled for November 11-13, 2024, in Boston, Massachusetts. Thomas Zindrick, the company's President, CEO, and Chairman, will present in a fireside chat discussing clinical-stage programs, recent announcements, and future milestones. Additionally, Genelux plans to hold one-on-one meetings with institutional investors during the conference. A webcast of the event will be made accessible, along with an archived replay for later viewing.

Market Sentiment Analysis

POSITIVE FACTORS

  • Genelux is participating in an important healthcare conference.
  • The event provides an opportunity for discussing clinical-stage programs.
  • Engagements with institutional investors can boost company visibility.

Full Press Release Details

WESTLAKE VILLAGE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at the Guggenheim Inaugural Healthcare Innovation Conference, taking place November 11-13, 2024, in Boston, Massachusetts.
The conversation with Brittany Stopa, MD, Biotech Equity Research Analyst at Guggenheim, is scheduled to begin at 1:30 p.m. ET on Monday, November 11, 2024. A webcast link for the Guggenheim Conference event will be available at https://wsw.com/webcast/guggen/gnlx/1958805. An archived replay will be available for approximately 90 days following the event on the company’s IR page.
The Company will also attend one-on-one meetings during the conference. Institutional investors interested in arranging a meeting with Genelux management can register to attend the conference or contact genelux@allelecomms.com.
About Genelux Corporation
Investor and Media Contacts
Allele Communications, LLC
genelux@allelecomms.com

Tags

healthcare conference

Frequently Asked Questions

When is Genelux's presentation at the Guggenheim conference?

Genelux's presentation will be on November 11, 2024.

Who will Thomas Zindrick have a conversation with?

He will discuss with Brittany Stopa, a Biotech Equity Research Analyst.

How can I access the webcast of the conference?

The webcast link can be found at https://wsw.com/webcast/guggen/gnlx/1958805.

Will there be a replay of the event?

Yes, an archived replay will be available for about 90 days.

How can investors meet with Genelux management?

Investors can register for the conference or email genelux@allelecomms.com.

Tags: GNLX Viatris Investor Conferences Healthcare Genelux Guggenheim healthcare conference clinical-stage programs immuno-oncology
Last updated: Nov 6, 2024